This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 May;16(7):1117-8.

doi: 10.1517/14656566.2015.1035013. Epub 2015 Apr 6.

Current lipid-modifying agents

Aris P Agouridis¹, Theodosios D Filippatos, Niki Katsiki

Affiliations

PMID: 25845932
DOI: 10.1517/14656566.2015.1035013

Comment

Current lipid-modifying agents

Aris P Agouridis et al. Expert Opin Pharmacother. 2015 May.

. 2015 May;16(7):1117-8.

doi: 10.1517/14656566.2015.1035013. Epub 2015 Apr 6.

Authors

Aris P Agouridis¹, Theodosios D Filippatos, Niki Katsiki

Affiliation

¹ University of Ioannina, Medical School, Department of Internal Medicine , 45110 Ioannina , Greece.

PMID: 25845932
DOI: 10.1517/14656566.2015.1035013

No abstract available

PubMed Disclaimer

Comment on

Ongoing challenges for pharmacotherapy for dyslipidemia.
Pisaniello AD, Scherer DJ, Kataoka Y, Nicholls SJ. Pisaniello AD, et al. Expert Opin Pharmacother. 2015 Feb;16(3):347-56. doi: 10.1517/14656566.2014.986094. Epub 2014 Dec 5. Expert Opin Pharmacother. 2015. PMID: 25476544 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information